Per Me - About the company
Per Me is an unfunded company based in Herzliya (Israel), founded in 2022 by Igal Chertkow. It operates as a Digital health platform that leverages DNA profiling to revolutionize personalized healthcare. Per Me has not raised any funding yet. The company has 6 active competitors, including 1 that is funded. Its top competitors include companies like Nest Genomics, Purna AI and Medneon.
Company Details
Digital health platform that leverages DNA profiling to revolutionize personalized healthcare. The technology enables individuals to access their genetic information, gaining insights into their health and wellness. It converts biological data into digital output resulting in health recommendations and telehealth consultations.
- Website
- permedna.com
- Email ID
- *****@permedna.com
Key Metrics
Founded Year
2022
Location
Herzliya, Israel
Stage
Unfunded
Ranked
2nd among 6 active competitors
Employee Count
16 as on Jun 30, 2026
Similar Companies
Sign up to download Per Me's company profile
Per Me's funding and investors
Per Me has not raised any funding rounds yet.
Per Me's founders and board of directors
Founder? Claim ProfileThe founders of Per Me is Igal Chertkow.
Here are the details of Per Me's key team members:
- Igal Chertkow: Co-Founder & CTO of Per Me.
View details of Per Me's Founder profiles and Board Members
Per Me's employee count trend
Per Me has 16 employees as of Jun 26. Here is Per Me's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Per Me's Competitors and alternates
Top competitors of Per Me include Nest Genomics, Purna AI and Medneon. Here is the list of Top 10 competitors of Per Me, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Nest Genomics 2022, Manhattan (United States), Seed | Provider of online genetic testing information platform for organizations | $9M | 44/100 | |
2nd | Digital health platform that leverages DNA profiling to revolutionize personalized healthcare | - | - | 35/100 | |
3rd | Provider of molecular intelligence platform focused on biology and life sciences research | - | - | 24/100 | |
4th | Medneon 2018, Cupertino (United States), Unfunded | Genetic virtual care for patients and providers | - | - | 16/100 |
5th | ![]() Genetic Insights London (United Kingdom), Unfunded | Provider of personalized health reports based on DNA analysis | - | - | 16/100 |
6th | GeneLeaf 2018, San Francisco (United States), Unfunded | Cloud-based application to support the analysis of hereditary relationships | - | - | 15/100 |
Looking for more details on Per Me's competitors? Click here to see the top ones
Per Me's Investments and acquisitions
Per Me has made no investments or acquisitions yet.
Reports related to Per Me
Here is the latest report on Per Me's sector:
Are you a Founder ?
FAQs about Per Me
Explore our recently published companies
- Smt. BNB Swaminarayan Pharmacy College - Valsad based, 2006 founded, Unfunded company
- Intraoralscanners - Unfunded company
- D-Pops Group - Tokyo based, Unfunded company
- InovaSkin - Rapid City based, Unfunded company
- Suiseino - Germany based, Unfunded company
- Huilerie Morisset - France based, 2010 founded, Unfunded company

